206 related articles for article (PubMed ID: 33755158)
1. Early-Onset Pancreas Cancer: Clinical Descriptors, Genomics, and Outcomes.
Varghese AM; Singh I; Singh R; Kunte S; Chou JF; Capanu M; Wong W; Lowery MA; Stadler ZK; Salo-Mullen E; Saadat LV; Wei AC; Reyngold M; Basturk O; Benayed R; Mandelker D; Iacobuzio-Donahue CA; Kelsen DP; Park W; Yu KH; O'Reilly EM
J Natl Cancer Inst; 2021 Sep; 113(9):1194-1202. PubMed ID: 33755158
[TBL] [Abstract][Full Text] [Related]
2. Pathogenic genomic alterations in Chinese pancreatic cancer patients and their therapeutical implications.
Zhao Z; Li X; Wang F; Xu Y; Liu S; Han Q; Yang Z; Huang W; Yin Z; Liu Q; Tan H; Ma T; Si S; Huang J; Yuan H; Li W; Liu R
Cancer Med; 2023 May; 12(10):11672-11685. PubMed ID: 36999792
[TBL] [Abstract][Full Text] [Related]
3. Risk of Syndrome-Associated Cancers Among First-Degree Relatives of Patients With Pancreatic Ductal Adenocarcinoma With Pathogenic or Likely Pathogenic Germline Variants.
Chen X; Meyer MA; Kemppainen JL; Horibe M; Chandra S; Majumder S; Petersen GM; Rabe KG
JAMA Oncol; 2023 Jul; 9(7):955-961. PubMed ID: 37200008
[TBL] [Abstract][Full Text] [Related]
4. Clinical and genomic characterisation of early-onset pancreatic cancer.
Castet F; Fabregat-Franco C; Castillo G; Navarro V; Sierra A; Acosta DA; López-Valbuena D; Dienstmann R; Tabernero J; Vivancos A; Tian TV; Macarulla T
Eur J Cancer; 2023 Nov; 194():113338. PubMed ID: 37793216
[TBL] [Abstract][Full Text] [Related]
5. Early-onset pancreatic cancer: a population-based study using the SEER registry.
Ansari D; Althini C; Ohlsson H; Andersson R
Langenbecks Arch Surg; 2019 Aug; 404(5):565-571. PubMed ID: 31377855
[TBL] [Abstract][Full Text] [Related]
6. Early-onset pancreatic cancer: A national cancer registry study from the Czech Republic and review of the literature.
Whitley A; Kocián P; Nikov A; Krejčí D; Pehalová L; Blaha M; Dušek L; Gürlich R
J Hepatobiliary Pancreat Sci; 2023 Dec; 30(12):1324-1333. PubMed ID: 37750364
[TBL] [Abstract][Full Text] [Related]
7. Delving into Early-onset Pancreatic Ductal Adenocarcinoma: How Does Age Fit In?
Tsang ES; Topham JT; Karasinska JM; Lee MKC; Williamson LM; Mendis S; Denroche RE; Jang GH; Kalloger SE; Moore RA; Mungall AJ; Bathe OF; Tang PA; Notta F; Wilson JM; Laskin J; O'Kane GM; Knox JJ; Goodwin RA; Loree JM; Jones SJM; Marra MA; Gallinger S; Schaeffer DF; Renouf DJ
Clin Cancer Res; 2021 Jan; 27(1):246-254. PubMed ID: 32958704
[TBL] [Abstract][Full Text] [Related]
8. Alterations in driver genes are predictive of survival in patients with resected pancreatic ductal adenocarcinoma.
McIntyre CA; Lawrence SA; Richards AL; Chou JF; Wong W; Capanu M; Berger MF; Donoghue MTA; Yu KH; Varghese AM; Kelsen DP; Park W; Balachandran VP; Kingham TP; D'Angelica MI; Drebin JA; Jarnagin WR; Iacobuzio-Donahue CA; Allen PJ; O'Reilly EM
Cancer; 2020 Sep; 126(17):3939-3949. PubMed ID: 32573775
[TBL] [Abstract][Full Text] [Related]
9. Demographic, clinical, and pathological features of early onset pancreatic cancer patients.
Ntala C; Debernardi S; Feakins RM; Crnogorac-Jurcevic T
BMC Gastroenterol; 2018 Sep; 18(1):139. PubMed ID: 30208959
[TBL] [Abstract][Full Text] [Related]
10. Prospective study of germline genetic testing in incident cases of pancreatic adenocarcinoma.
Brand R; Borazanci E; Speare V; Dudley B; Karloski E; Peters MLB; Stobie L; Bahary N; Zeh H; Zureikat A; Hogg M; Lee K; Tsung A; Rhee J; Ohr J; Sun W; Lee J; Moser AJ; DeLeonardis K; Krejdovsky J; Dalton E; LaDuca H; Dolinsky J; Colvin A; Lim C; Black MH; Tung N
Cancer; 2018 Sep; 124(17):3520-3527. PubMed ID: 30067863
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic cancer in young adults - an evolving entity?
Li Y; Zhang X
Am J Cancer Res; 2023; 13(7):2763-2772. PubMed ID: 37559978
[TBL] [Abstract][Full Text] [Related]
12. Pancreas cancer and BRCA: A critical subset of patients with improving therapeutic outcomes.
Momtaz P; O'Connor CA; Chou JF; Capanu M; Park W; Bandlamudi C; Berger MF; Kelsen DP; Suehnholz SP; Chakravarty D; Yu KH; Varghese AM; Zervoudakis A; Li J; Ku GY; Park JS; Shcherba M; Harding JJ; Goldberg Z; Abou-Alfa GK; Salo-Mullen EE; Stadler ZK; Iacobuzio-Donahue CA; O'Reilly EM
Cancer; 2021 Dec; 127(23):4393-4402. PubMed ID: 34351646
[TBL] [Abstract][Full Text] [Related]
13. Leptomeningeal disease in pancreas ductal adenocarcinoma: A manifestation of longevity.
O'Connor CA; Park JS; Kaley T; Kezlarian B; Edelweiss M; Yang TJ; Park W; Reidy D; Varghese AM; Yu KH; O'Reilly EM
Pancreatology; 2021 Apr; 21(3):599-605. PubMed ID: 33582005
[TBL] [Abstract][Full Text] [Related]
14. Genomic Landscape of Pancreatic Adenocarcinoma in Younger versus Older Patients: Does Age Matter?
Ben-Aharon I; Elkabets M; Pelossof R; Yu KH; Iacubuzio-Donahue CA; Leach SD; Lowery MA; Goodman KA; O'Reilly EM
Clin Cancer Res; 2019 Apr; 25(7):2185-2193. PubMed ID: 30617137
[TBL] [Abstract][Full Text] [Related]
15. Clinical Impact of Pathogenic Germline Variants in Pancreatic Cancer: Results From a Multicenter, Prospective, Universal Genetic Testing Study.
Uson PLS; Samadder NJ; Riegert-Johnson D; Boardman L; Borad MJ; Ahn D; Sonbol MB; Faigel DO; Fukami N; Pannala R; Kunze K; Golafshar M; Klint M; Esplin ED; Nussbaum RL; Stewart AK; Bekaii-Saab T
Clin Transl Gastroenterol; 2021 Oct; 12(10):e00414. PubMed ID: 34620795
[TBL] [Abstract][Full Text] [Related]
16. Health Disparities in Presentation, Treatment, Genomic Testing, and Outcomes of Pancreatic Cancer in Hispanic and Non-Hispanic Patients.
Halder R; Veeravelli S; Cheng C; Estrada-Mendizabal RJ; Recio-Boiles A
J Racial Ethn Health Disparities; 2023 Dec; 10(6):3131-3139. PubMed ID: 37071331
[TBL] [Abstract][Full Text] [Related]
17. Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma.
Shindo K; Yu J; Suenaga M; Fesharakizadeh S; Cho C; Macgregor-Das A; Siddiqui A; Witmer PD; Tamura K; Song TJ; Navarro Almario JA; Brant A; Borges M; Ford M; Barkley T; He J; Weiss MJ; Wolfgang CL; Roberts NJ; Hruban RH; Klein AP; Goggins M
J Clin Oncol; 2017 Oct; 35(30):3382-3390. PubMed ID: 28767289
[TBL] [Abstract][Full Text] [Related]
18. The Pancreatic Cancer Early Detection (PRECEDE) Study is a Global Effort to Drive Early Detection: Baseline Imaging Findings in High-Risk Individuals.
Zogopoulos G; Haimi I; Sanoba SA; Everett JN; Wang Y; Katona BW; Farrell JJ; Grossberg AJ; Paiella S; Klute KA; Bi Y; Wallace MB; Kwon RS; Stoffel EM; Wadlow RC; Sussman DA; Merchant NB; Permuth JB; Golan T; Raitses-Gurevich M; Lowy AM; Liau J; Jeter JM; Lindberg JM; Chung DC; Earl J; Brentnall TA; Schrader KA; Kaul V; Huang C; Chandarana H; Smerdon C; Graff JJ; Kastrinos F; Kupfer SS; Lucas AL; Sears RC; Brand RE; Parmigiani G; Simeone DM;
J Natl Compr Canc Netw; 2024 Apr; 22(3):158-166. PubMed ID: 38626807
[TBL] [Abstract][Full Text] [Related]
19. Early-onset pancreatic cancer: a review of molecular mechanisms, management, and survival.
Ulanja MB; Moody AE; Beutler BD; Antwi-Amoabeng D; Rahman GA; Alese OB
Oncotarget; 2022; 13():828-841. PubMed ID: 35720978
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and spectrum of pathogenic germline variants in intestinal and pancreatobiliary type of ampullary cancer.
Kumari N; Singh RK; Mishra SK; L R; Mohindra S; Krishnani N
Pathol Res Pract; 2021 Jan; 217():153309. PubMed ID: 33341547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
